{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:17Z","timestamp":1789560137854,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Investigate the association between use of depot medroxyprogesterone acetate (DMPA) (an injectable progestin-only contraceptive) and leiomyoma development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      We conducted a cohort study in the Detroit, Michigan, area that involved four clinic visits at 20-month intervals over 5 years (2010\u20132018) and used a standardized ultrasonography protocol to prospectively measure leiomyomas 0.5 cm or more in diameter. Participants were 1,693 self-identified Black women aged 23\u201335 years with no prior leiomyoma diagnosis and no hysterectomy. For this substudy, years since last use of DMPA was ascertained from questionnaire data at every visit.\n                      <jats:italic toggle=\"yes\">Leiomyoma incidence<\/jats:italic>\n                      was defined as the first visit with an observed leiomyoma among women who were leiomyoma-free at enrollment. Depot medroxyprogesterone acetate associations were examined with Cox models.\n                      <jats:italic toggle=\"yes\">Leiomyoma growth<\/jats:italic>\n                      was calculated as the change in log-volume for leiomyomas matched at successive visits and was modeled using linear mixed models accounting for clustered data.\n                      <jats:italic toggle=\"yes\">Leiomyoma loss<\/jats:italic>\n                      , defined as a reduction in leiomyoma number in successive visits, was modeled using Poisson regression. All models used time-varying exposure and covariates.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of participants with at least one follow-up visit (N=1,610), 42.9% had ever used DMPA. Participants exposed to DMPA within the previous 2 years experienced reduced leiomyoma development during the subsequent observation interval compared with never users, including lower leiomyoma incidence (5.2% vs 10.7%), adjusted hazard ratio 0.6 (95% CI 0.4\u20131.0), 42.0% lower leiomyoma growth (95% CI \u221251.4 to \u221230.7) and 60% greater leiomyoma loss (adjusted risk ratio 1.6, 95% CI 1.1\u20132.2). Excess leiomyoma loss was also seen for those who used DMPA 2\u20134 years before the visit compared with never users, 2.1-fold increase (95% CI 1.4\u20133.1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Recent use of DMPA was associated with reduced leiomyoma development and increased leiomyoma loss. Such changes in early leiomyoma development in young women could delay symptom onset and reduce the need for invasive treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004745","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T14:04:20Z","timestamp":1652709860000},"page":"797-807","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Depot Medroxyprogesterone Acetate Use and the Development and Progression of Uterine Leiomyoma"],"prefix":"10.1097","volume":"139","author":[{"given":"Quaker E.","family":"Harmon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy A.","family":"Patchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Umbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna D.","family":"Baird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"e2014.00096","DOI":"10.4293\/JSLS.2014.00096","article-title":"Updated hysterectomy surveillance and factors associated with minimally invasive hysterectomy","volume":"18","author":"Cohen","year":"2014","journal-title":"JSLS"},{"key":"R4-20260916","first-page":"482","article-title":"Rates and routes of hysterectomy for benign indications in Austria 2002 - 2014","volume":"77","author":"Edler","year":"2017","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R5-20260916","first-page":"359","article-title":"A decade of hysterectomy in a tertiary hospital in urban Niger-Delta region of Nigeria","volume":"11","author":"Abe","year":"2008","journal-title":"Niger J Clin Pract"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/AOG.0000000000004401","article-title":"Management of symptomatic uterine leiomyomas","volume":"137","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of uterine fibroids: from menarche to menopause","volume":"59","author":"Wise","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/humrep\/dev069","article-title":"Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women","volume":"30","author":"Harmon","year":"2015","journal-title":"Hum Reprod"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American Women: a prospective study","volume":"159","author":"Wise","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study","volume":"103","author":"Lumbiganon","year":"1996","journal-title":"BJOG"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/jwh.2015.5277","article-title":"A prospective, ultrasound-based study to evaluate risk factors for uterine fibroid incidence and growth: methods and results of recruitment","volume":"24","author":"Baird","year":"2015","journal-title":"J Womens Health (Larchmt)"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/AOG.0b013e318197bbaf","article-title":"Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study","volume":"113","author":"Laughlin","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.7863\/ultra.33.7.1217","article-title":"Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth","volume":"33","author":"Moshesh","year":"2014","journal-title":"J Ultrasound Med"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1067\/mob.2002.121725","article-title":"Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas","volume":"186","author":"Dueholm","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.contraception.2020.07.093","article-title":"Reasons for hormonal contraceptive use in a cohort of African-American women living in the Detroit area","volume":"102","author":"Hoffman","year":"2020","journal-title":"Contraception"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"496.e1","DOI":"10.1016\/j.ajog.2011.02.018","article-title":"Postpartum factors and natural fibroid regression","volume":"204","author":"Laughlin","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2020.02.016","article-title":"Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans","volume":"223","author":"Baird","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal Black and White women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/01443610400009543","article-title":"Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study","volume":"24","author":"Venkatachalam","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.11.015","article-title":"Hormones and pathogenesis of uterine fibroids","volume":"34","author":"Reis","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1055\/s-0035-1558451","article-title":"Uterine leiomyoma stem cells: linking progesterone to growth","volume":"33","author":"Bulun","year":"2015","journal-title":"Semin Reprod Med"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/0192623311401045","article-title":"Effects of hormonally active agents on steroid hormone receptor expression and cell proliferation in the myometrium of ovariectomized macaques","volume":"39","author":"Hill","year":"2011","journal-title":"Toxicol Pathol"},{"key":"R26-20260916","first-page":"431","article-title":"Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium","volume":"96","author":"Miller","year":"2000","journal-title":"Obstet Gynecol"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1210\/er.2017-00103","article-title":"Hormonal contraception and HIV-1 acquisition: biological mechanisms","volume":"39","author":"Hapgood","year":"2018","journal-title":"Endocr Rev"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.3390\/ijms21072625","article-title":"Progestins related to progesterone and testosterone elicit divergent human endometrial transcriptomes and biofunctions","volume":"21","author":"Houshdaran","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0010-7824(97)00172-8","article-title":"Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women","volume":"56","author":"Hunter","year":"1997","journal-title":"Contraception"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/AOG.0000000000003089","article-title":"Side effects and health benefits of depot medroxyprogesterone acetate: a systematic review","volume":"133","author":"Dianat","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/01.AOG.0000450758.95422.c8","article-title":"Depot medroxyprogesterone acetate and bone effects","volume":"123","year":"2014","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:46Z","timestamp":1789556626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000004745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004745","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"2021-11-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}